Rankin PM, Harrison S, Chong WK, Boyd S, Aylett SE
[22] B 12 deficiency in pregnant women is increasingly common [23] and has been shown to be associated with major maternal health implications, including increased obesity, [23] higher body mass index (BMI), [24] insulin resistance, [22] gestational diabetes, and type 2 diabetes (T2D) in later life
Intramuscular administration allows for efficient absorption of vitamin B12 into the bloodstream, ensuring rapid availability for the bodys essential functions
What they found: Oral AOD-9604 reduced body fat by 18 to 22 % vs placebo, comparable to injection administration No changes in total body weight (because lean mass rose slightly) Decrease in plasma triglycerides by 30 % Decrease in resting free fatty acids (paradoxically, mobilization of fat from depots into oxidation) No GI side effects Why it matters: It suggested that AOD-9604 could work orally , a rare property for a peptide
Nicotinamide N-methyltransferase: a novel therapeutic target